Transcranial Electrical Stimulation for Cervical Dystonia
1 other identifier
interventional
36
1 country
1
Brief Summary
There are two phases. Phase I: A single visit which includes a screening, clinical scales, and a MRI scan with simultaneous tES/sham tES in a randomized block design. Enrolls both Cervical Dystonia (CD) patients and healthy controls. Phase II: 5 consecutive days of 30-90 min visits to campus for tES or sham tES. Transcranial magnetic stimulation (TMS) measures and clinical scales will also be included on Day 1 and Day 5 visits. Enrolls only CD patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 27, 2017
CompletedFirst Submitted
Initial submission to the registry
November 29, 2017
CompletedFirst Posted
Study publicly available on registry
December 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2021
CompletedApril 25, 2022
April 1, 2022
3.9 years
November 29, 2017
April 21, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Phase I: A change in brain functional connectivity in primary cervical dystonia
A change in mean functional connectivity between the pallidum and putamen during a resting state in CD patients during inhibitory tACS targeting the sensorimotor network.
Day 1
Phase II: Improvement in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) score
A change in TWSTRS scores following five daily sessions of inhibitory tACS.
Day 1, Day 5
Study Arms (6)
MRI - HC tDCS
ACTIVE COMPARATORHealthy controls in Phase 1 transcranial electrical stimulation set to direct current
MRI - HC tACS
ACTIVE COMPARATORHealthy controls in Phase 1- transcranial electrical stimulation set to alternating current
MRI - CD tCDS
ACTIVE COMPARATORCervical dystonia in Phase 1 transcranial electrical stimulation set to direct current
MRI - CD tACS
ACTIVE COMPARATORCervical dystonia in Phase 1 transcranial electrical stimulation set to alternating current
Phase II - Stim
ACTIVE COMPARATORCervical dystonia in Phase 2 transcranial electrical stimulation setting is active
Phase II - Sham
SHAM COMPARATORCervical dystonia in Phase 2 transcranial electrical stimulation setting is sham
Interventions
The device is a Neoprene headcap that holds an array of padded electrodes close to the scalp to stimulate the underlying brain.
Eligibility Criteria
You may qualify if:
- Right-handed
- On a stable dose of all medications used to treat dystonia for the month previous to enrollment
- No botox injections in the 10 weeks previous to enrollment
You may not qualify if:
- Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures, significant systemic medical conditions, untreated psychiatric or neurological conditions)
- Evidence on neurological exam of any potentially confounding neurological disorder
- Evidence of significant cognitive impairment
- Patients with dystonia symptoms beginning prior to the age of 18 will be excluded
- Patients with secondary dystonia resulting from medications or that are part of another neurological disorder (e.g. Parkinson's disease) will be excluded
- Medication that might predispose the subject to seizures
- Healthy Controls
- \- Right-handed
- Any contraindication to MRI scanning, tES, or TMS (e.g pregnancy, history of seizures, significant systemic medical conditions, untreated psychiatric or neurological conditions)
- Evidence on neurological exam of any potentially confounding neurological disorder
- Evidence of significant cognitive impairment
- Medication that might predispose the subject to seizures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Denver
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Berman, MD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2017
First Posted
December 12, 2017
Study Start
October 27, 2017
Primary Completion
September 20, 2021
Study Completion
September 20, 2021
Last Updated
April 25, 2022
Record last verified: 2022-04